DnB Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-177,045
Closed -$880K 660
2022
Q2
$880K Buy
177,045
+80,111
+83% +$420K 0.01% 605
2022
Q1
$689K Buy
+96,934
New +$802K ﹤0.01% 616

Other funds holding CELL

DnB Asset Management's CELL Position: Q3 2022 in Review

DnB Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 177,045 shares — an estimated $880K sold.

DnB Asset Management first reported a position in CELL in Q1 2022 and held it in 2 quarters. The position peaked at $880K in Q2 2022. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • DnB Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • DnB Asset Management sold 177,045 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $880K.
  • DnB Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • DnB Asset Management's PhenomeX Inc. Common Stock position peaked at $880K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on DnB Asset Management's 13F filing for Q3 2022, filed 11 Oct 2022.